289 related articles for article (PubMed ID: 16690721)
21. The regulatory effect of tamoxifen on fibronectin expression in estrogen-dependent MCF-7 breast carcinoma cells.
Horii Y; Takei H; Koibuchi Y; Horiguchi J; Maemura M; Iino Y; Morishita Y
Oncol Rep; 2006 May; 15(5):1191-5. PubMed ID: 16596185
[TBL] [Abstract][Full Text] [Related]
22. Integrative analysis of gene expression patterns predicts specific modulations of defined cell functions by estrogen and tamoxifen in MCF7 breast cancer cells.
Gadal F; Starzec A; Bozic C; Pillot-Brochet C; Malinge S; Ozanne V; Vicenzi J; Buffat L; Perret G; Iris F; Crepin M
J Mol Endocrinol; 2005 Feb; 34(1):61-75. PubMed ID: 15691878
[TBL] [Abstract][Full Text] [Related]
23. Glucuronidation of active tamoxifen metabolites by the human UDP glucuronosyltransferases.
Sun D; Sharma AK; Dellinger RW; Blevins-Primeau AS; Balliet RM; Chen G; Boyiri T; Amin S; Lazarus P
Drug Metab Dispos; 2007 Nov; 35(11):2006-14. PubMed ID: 17664247
[TBL] [Abstract][Full Text] [Related]
24. Down-regulation of CXCR4 expression by tamoxifen is associated with DNA methyltransferase 3B up-regulation in MCF-7 breast cancer cells.
Kubarek Ł; Kozłowska A; Przybylski M; Lianeri M; Jagodzinski PP
Biomed Pharmacother; 2009 Sep; 63(8):586-91. PubMed ID: 19019622
[TBL] [Abstract][Full Text] [Related]
25. The active tamoxifen metabolite endoxifen (4OHNDtam) strongly down-regulates cytokeratin 6 (CK6) in MCF-7 breast cancer cells.
Helland T; Gjerde J; Dankel S; Fenne IS; Skartveit L; Drangevåg A; Bozickovic O; Flågeng MH; Søiland H; Mellgren G; Lien EA
PLoS One; 2015; 10(4):e0122339. PubMed ID: 25867603
[TBL] [Abstract][Full Text] [Related]
26. PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer.
Ghosh MG; Thompson DA; Weigel RJ
Cancer Res; 2000 Nov; 60(22):6367-75. PubMed ID: 11103799
[TBL] [Abstract][Full Text] [Related]
27. Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth.
Coezy E; Borgna JL; Rochefort H
Cancer Res; 1982 Jan; 42(1):317-23. PubMed ID: 7053859
[TBL] [Abstract][Full Text] [Related]
28. Dietary genistein negates the inhibitory effect of tamoxifen on growth of estrogen-dependent human breast cancer (MCF-7) cells implanted in athymic mice.
Ju YH; Doerge DR; Allred KF; Allred CD; Helferich WG
Cancer Res; 2002 May; 62(9):2474-7. PubMed ID: 11980635
[TBL] [Abstract][Full Text] [Related]
29. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen.
Chen J; Power KA; Mann J; Cheng A; Thompson LU
Exp Biol Med (Maywood); 2007 Sep; 232(8):1071-80. PubMed ID: 17720953
[TBL] [Abstract][Full Text] [Related]
30. C-myc overexpression, c-mil, c-myb expression in a breast tumor cell line. Effects of estrogen and antiestrogen.
Collyn-d'Hooghe M; Vandewalle B; Hornez L; Lantoine D; Revillion F; Lefebvre J; Kerckaert JP
Anticancer Res; 1991; 11(6):2175-9. PubMed ID: 1776859
[TBL] [Abstract][Full Text] [Related]
31. GREB 1 is a critical regulator of hormone dependent breast cancer growth.
Rae JM; Johnson MD; Scheys JO; Cordero KE; Larios JM; Lippman ME
Breast Cancer Res Treat; 2005 Jul; 92(2):141-9. PubMed ID: 15986123
[TBL] [Abstract][Full Text] [Related]
32. Dietary flaxseed enhances the inhibitory effect of tamoxifen on the growth of estrogen-dependent human breast cancer (mcf-7) in nude mice.
Chen J; Hui E; Ip T; Thompson LU
Clin Cancer Res; 2004 Nov; 10(22):7703-11. PubMed ID: 15570004
[TBL] [Abstract][Full Text] [Related]
33. Tamoxifen metabolite endoxifen interferes with the polyamine pathway in breast cancer.
Thomas TJ; Thomas T; John S; Hsu HC; Yang P; Keinänen TA; Hyvönen MT
Amino Acids; 2016 Oct; 48(10):2293-302. PubMed ID: 27438264
[TBL] [Abstract][Full Text] [Related]
34. Tamoxifen metabolites as active inhibitors of aromatase in the treatment of breast cancer.
Lu WJ; Desta Z; Flockhart DA
Breast Cancer Res Treat; 2012 Jan; 131(2):473-81. PubMed ID: 21390495
[TBL] [Abstract][Full Text] [Related]
35. Induction of two estrogen-responsive proteins by antiestrogens in R27, a tamoxifen-resistant clone of MCF7 cells.
Vignon F; Lippman ME; Nawata H; Derocq D; Rochefort H
Cancer Res; 1984 May; 44(5):2084-8. PubMed ID: 6713400
[TBL] [Abstract][Full Text] [Related]
36. Bisphenol-A and estradiol exert novel gene regulation in human MCF-7 derived breast cancer cells.
Singleton DW; Feng Y; Chen Y; Busch SJ; Lee AV; Puga A; Khan SA
Mol Cell Endocrinol; 2004 Jun; 221(1-2):47-55. PubMed ID: 15223131
[TBL] [Abstract][Full Text] [Related]
37. Effects of the antiestrogens tamoxifen and raloxifene on the estrogen receptor transactivation machinery.
Glaeser M; Niederacher D; Djahansouzi S; Hanstein B; Dittrich R; Beckmann MW; Fasching PA; Ackermann S
Anticancer Res; 2006; 26(1B):735-44. PubMed ID: 16739346
[TBL] [Abstract][Full Text] [Related]
38. Estrogen receptor alpha/beta isoforms, but not betacx, modulate unique patterns of gene expression and cell proliferation in Hs578T cells.
Secreto FJ; Monroe DG; Dutta S; Ingle JN; Spelsberg TC
J Cell Biochem; 2007 Aug; 101(5):1125-47. PubMed ID: 17520659
[TBL] [Abstract][Full Text] [Related]
39. Luteolin sensitises drug-resistant human breast cancer cells to tamoxifen via the inhibition of cyclin E2 expression.
Tu SH; Ho CT; Liu MF; Huang CS; Chang HW; Chang CH; Wu CH; Ho YS
Food Chem; 2013 Nov; 141(2):1553-61. PubMed ID: 23790951
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells.
Menendez JA; Oza BP; Atlas E; Verma VA; Mehmi I; Lupu R
Oncogene; 2004 Jun; 23(28):4945-58. PubMed ID: 15094777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
